ImmunityBio (NASDAQ: IBRX) is a mid-cap drugmaker making waves in this niche right now; the company's shares have soared over the last 12 months. Although ImmunityBio appears promising, investors ...
Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...
ISC Class 12 Biology Exam 2026 was conducted on 6 March 2026 from 2:00 PM to 5:00 PM by the Council for the Indian School Certificate Examinations (CISCE). Biology is an important subject for Class 12 ...
Supplements, surprising treatments, immunity-boosting vaccines and even exercises can help the immune system do its job ...
Providing targeted supplementation is essential to address the cow's nutritional needs, meet production goals & optimize ...
Moderna, Inc. settles LNP patent dispute for $950M, securing royalty-free tech access and legal clarity; click for what it ...
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Major updates include Supreme Court GST classification rulings, IBC jurisdiction clarifications, DTAA amendment with France, and DGFT export relaxations. Compliance and enforcement landscape sees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results